Professor Dame Sally Davies will leave her post as chief medical officer for England and chief medical officer advisor to the UK government later this year to take up a new role.
11th February 2019
The Association of the British Pharmaceutical Industry (ABPI) has expressed fears that the UK will drop out of the “safest medicines system in the world” in the event of no-deal Brexit.
11th February 2019
UniQure's experimental gene therapy has shown sustained Factor IX activity in a Phase II study assessing its potential to treat haemophilia B.
11th February 2019
Grey Wolf Therapeutics has completed a £10 million series A financing to fund development of immuno-oncology therapies to increase tumour visibility.
11th February 2019
Cases of measles in Europe are at the highest rate in a decade, due to a growing number of pockets where parents are refusing vaccination for their children, also known as ‘anti-vaxxers’.
8th February 2019
The NHS has announced plans to rollout lung cancer scanning trucks across the country, operating from supermarket car parks and aiming to save lives by catching the condition early.
8th February 2019
Older patients may be spared dementia and falls by a new NHS tech roll-out, via digital checks that aim to save lives through diagnosis of sepsis, and other tools being made available in hospitals across the country as part of the NHS Long Term Plan.
8th February 2019
Solid Biosciences' shares have taken a hit after early results from a study of SGT-001 microdystrophin gene transfer for the treatment of Duchenne muscular dystrophy (DMD) fell short.
8th February 2019
Eisai and Purdue Pharma have announced six-month results from the SUNRISE 2 Phase III clinical study evaluating the efficacy and safety of lemborexant.
8th February 2019
The National Institute for Health and Care Excellence (NICE) is working with the Canadian Agency for Drugs and Technology in Health (CADTH) to offer parallel scientific advice to the life sciences industry.
7th February 2019
The US Food and Drug Administration (FDA) has approved Sanofi's Cablivi as the first treatment for adult patients with a rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP).
7th February 2019
GlaxoSmithKline (GSK) has released its fourth-quarter 2018 results, reporting prescription drug sales of £4.8 billion - a 6% increase on the prior year period - and profit of £1.4 billion, marking an increase of £442 million.
7th February 2019
Zogenix has completed its rolling submission of a New Drug Application in the US and submitted a marketing application in Europe for Fintepla for the treatment of seizures associated with Dravet syndrome.
7th February 2019
Roche has announced that it has joined the World Federation of Hemophilia (WFH) Humanitarian Aid Program, a landmark initiative leading the effort to change the lack of access to care and treatment for people with inherited bleeding disorders in developing countries.
7th February 2019
AstraZeneca’s Fasenra has been awarded Orphan Drug Designation in the US for the treatment of hypereosinophilic syndrome (HES).
7th February 2019
